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Abstract
Background: Post kala-azar dermal leishmaniasis (PKDL), a sequel to visceral leishamaniasis (VL) in 5–15% cases, constitutes
a parasite reservoir important in disease transmission. The precise immunological cause of PKDL outcome remains obscure.
However, overlapping counter regulatory responses with elevated IFN-c and IL-10 are reported.
Methodology/Principal Findings: Present study deals with ex-vivo mRNA and protein analysis of natural regulatory T cells
(nTreg) markers (Foxp3, CD25 and CTLA-4) and IL-10 levels in lesion tissues of PKDL patients at pre and post treatment
stages. In addition, correlation of nTreg markers and IL-10 with parasite load in tissue lesions was investigated. mRNA levels
of nTreg markers and IL-10 were found significantly elevated in pre-treatment PKDL cases compared to controls (Foxp3,
P=0.0009; CD25 & CTLA-4, P,0.0001; IL-10, P,0.0001), and were restored after treatment. Analysis of nTreg cell markers
and IL-10 in different clinical manifestations of disease revealed elevated levels in nodular lesions compared to macules/
papules. Further, Foxp3, CD25 and IL-10 mRNA levels directly correlated with parasite load in lesions tissues.
Conclusion/Significance: Data demonstrated accumulation of nTreg cells in infected tissue and a correlation of both IL-10
and nTreg levels with parasite burden suggesting their role in disease severity in PKDL.
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Introduction
Leishmaniasis constitutes various forms of globally widespread
group of neglected diseases caused by an obligatory intracellular
protozoan parasite of genus Leishmania. It is currently endemic in
88 countries and overall prevalence is estimated as 12 million with
350 million at risk. Visceral leishmaniasis (VL) is the most severe
form, fatal if not treated. 90% of all VL cases world wide occur in
India, Bangladesh, Nepal, Brazil and Sudan [1]. In India,
Leishmania donovani causes VL or Kala azar (KA) and Post kala
azar dermal leishmaniasis (PKDL) while L. tropica is responsible for
cutaneous leishmaniasis (CL) in humans.
PKDL is an unusual dermatosis that develops in 5–15% of
apparently cured VL cases in India and in about 60% of cases in
Sudan [2]. This chronic skin condition produces gross cutaneous
lesions in the form of hypopigmented macules, erythema and
nodular stages. So far, little is known about the parasite/host
factors that drive the parasite to shift from site of initial infection
viscera (spleen or bone marrow) to the dermis or about the clinical
manifestation of the disease. Inadequate treatment is considered to
be a factor in PKDL development; however, the disease may
develop even after complete treatment. Factors such as genetics
and nutrition may be important [2] and remain to be explored in
Indian PKDL.
The precise immunological cause remains obscure. In Sudanese
PKDL,immunesuppression,reinfectionorreactivationisconsideredto
bethe majorunderlyingcause ofPKDLdevelopment[2].Reactivation
ofdiseaseintheformofPKDLissuggested,onaccountofretentionand
maintenance of residual IL-10 and TGF-b levels in sodium antimony
gluconate (SAG) treated KA individuals [3]. However, current reports
suggest that PKDL may develop even after treatment with anti-
leishmanial drugs such as Amphotericin B or Miltefosine. Thus, other
mechanisms may be responsible for disease development.
Like human VL, elevated levels of IFN-c and TNF-a are
reported systemicallyorinlesion tissues ofPKDLwith simultaneous
presence of immunosuppressive cytokine, IL-10, suggesting that
there is no defect in mounting antigen specific responses [4]. Direct
correlation between circulating IL-10 levels with parasite load
suggestsrole ofIL-10incompromising theeffector T cellfunctionin
human VL [5,6]. In, addition IL-10 knockout mice are highly
resistant to L. donovani infection and treatment with anti-IL-10
receptor antibody promotes clinical cure [7].
Several IL-10–producing CD4
+ T cell subpopulations have been
described, among them naturally occurring CD4
+CD25
+Foxp3
+
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ability to inhibit the response of other T cells. It is characterized by
the constitutive expression of IL-2R-a chain (CD25) and by
expression of the transcriptional factor, Foxp3. Evidence from
experimental murine models of L. major infection suggests that nTreg
cells promote survival of Leishmania parasites and reactivation of
disease [8]. In addition, in human CL intralesional nTreg have been
associated with SAG unresponsiveness and disease pathology [9,10].
In our previous report we proposed the role of nTreg in PKDL in
the context of overlapping counter-regulating cytokines and chronic
persistent infection [4]. The present study was carried out to
evaluate if nTreg and IL-10 have an influenceon disease persistence
inhuman.The studysupportstherole ofIL-10 andnTreg inPKDL
pathology, as evident from a direct correlation of IL-10 and Foxp3
mRNA levels with parasite load within lesion tissues.
Materials and Methods
Study subject and Tissue samples
Lesional skin tissues were collected from PKDL patients (n=25)
originating from Bihar and reporting to the Department of
Dermatology, Safdarjung Hospital, New Delhi (Table 1). Biopsies
were collected from face (n=19) or shoulder region (n=6). All
patients were HIV seronegative and diagnosis was confirmed by
microscopy and polymerase chain reaction, described previously
[4]. Furthermore, based on lesion types, PKDL patients were
categorized in 3 groups, nodular (N) (n=12), macular or papular
(M/P) (n=10) and polymorphic (n=3). Patients were treated with
oral Miltefosine (150 mg/day) for 2 months. Follow-up samples
were collected from the same site as at pre treatment stage one
month after completion of treatment in 8 cases, all of which
showed apparent clinical cure. Further no parasites were
detectable by real time PCR in any of these cases at this stage. 5
normal skin tissues were collected from the shoulder region of
healthy individuals.
Ethics Statement
The study was approved by and carried out under the guidelines
of the Ethical Committee of the Safdarjung Hospital, India. All
patients provided written informed consent for the collection of
samples and subsequent analysis.
Quantitative real times reverse transcription PCR
Punch biopsy (4–6 mm) samples were collected from PKDL
patients and healthy individuals in RNAlater (Ambion, Austin, TX,
USA) and stored in liquid nitrogen until use. Total RNA was
isolated using Trizol reagent, in accordance with the manufactur-
er’s instructions, and quality of RNA was assessed using
Bioanalyzer (Agilent, Foster City, CA, USA). Quantity of RNA
was determined by Nanodrop spectrophotometer (Thermo
Scientific, Wilmington, DE, USA). cDNA was synthesized from
2 mg of total RNA using High capacity cDNA synthesis kit
(Applied Biosystems, Foster City, CA, USA). Incubation condi-
tions for reverse transcription were 10 min at 25uC, followed by
2 hours at 37uC and were performed on a MasterCycler Gradient
(Eppendorf, Hamburg Germany).
Real-timepolymerasechainreactionwasperformedonanABIPrism
7000 sequence detection system (Applied Biosystems) using cDNA
specific FAM-MGB–labeled Taqman primer/probe sets (Applied
Biosystems) for IL-10 (Hs00174086_m1), CD25 (Hs00166229_m1),
CTLA-4 (Hs00175480_m1), Foxp3 (Hs00203958_m1). VIC-MGB
labeled 18S rRNA (4319413E) was used as endogenous control for
relativeamountofmRNAineachsample. Therelativequantificationof
products was determined by the number of cycles over endogenous
control required to detect the gene expression of interest.
Quantification of parasite load
PKDL skin lesion tissue (n=12) was collected in NET buffer
[150 mM NaCl, 15 mM Tris-HCl (pH 8.3) and 1 mM EDTA].
Tissue was homogenized in liquid nitrogen and DNA was
extracted using QIAamp DNA Tissue kit (QIAGEN) according
to manufacturer’s instructions. All samples were processed on the
same day and isolated DNA was stored at 280uC until use. DNA
samples from 3 patients who were part of our previous study [5]
were also included. SYBR Green I based Real-time PCR was used
for accurate quantification of parasite load as described previously
[5]. Briefly, PCR reaction was performed in an ABI Prism 7000
sequence detection system (Applied Biosystems) using forward
primer (59-CTTTTCTGGTCCTCCGGGTAGG-39), reverse
primer, (59-CCACCCGGCCCTATTTTACACCAA-39). A stan-
dard curve was constructed using 10-fold serially diluted L. donovani
parasite DNA corresponding to 10
4 to 0.1 parasite per reaction.
Table 1. Major characteristics of the study population.
Patients Characteristics
PKDL
(n=25)
Age (years) range, (mean±SD) 19–52, (27.7268.48)
Sex (M/F) 22/3
Cases reporting history of KA 19
History of KA, range in years, (mean±SD) 2–34, (10.5768.89)
Duration of PKDL, range in years, (mean±SD) 0.5–31, (5.266.85)
Type of lesions
Nodular 12
Macular/Papular 10
Polymorphic 3
Abbreviations: M=Male, F=Female, PKDL=Post kala azar dermal leishmaniasis,
KA=Kala azar.
doi:10.1371/journal.pntd.0001171.t001
Author Summary
Post kala azar dermal leishamniasis (PKDL), an unusual
dermatosis develops in 5–15% of apparently cured visceral
leishmaniasis cases in India and in about 60% of cases in
Sudan. PKDL cases assume importance since they consti-
tute a major human reservoir for the parasite. Inadequate
treatment of VL, genetics, nutrition and immunological
mechanisms that allow renewed multiplication of latent
parasites or reinfection predispose to PKDL. Immuno-
pathogenesis of PKDL is poorly understood. IL-10 is widely
accepted as an immuno-suppressive cytokine and pro-
duced by diverse cell populations including, B cells,
macrophages and CD4+ T cells. Natural T regulatory
(nTreg) cells are subpopulation of CD4+ T cells that inhibit
the response of other T cells. In this study we reported the
accumulation of nTreg cells in lesion tissues of PKDL
patients. Further correlation of Treg markers and IL-10 with
parasite load in lesion tissues suggested a role of IL-10 and
Treg in parasite establishment or persistence. Further
studies are warranted to explore antigen specific IL-10
source in lesion tissues and unravel the concerted
induction or accumulation of Treg in PKDL.
Natural T Regulatory Cells in PKDL
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Punch biopsy skin tissue was collected in neutralized formaline.
The tissue was paraffin embedded and 5 mm sections were prepared
on polylysine coated glass slides from all skin specimens.
Immunohistochemical staining was performed using a standard
polymer-peroxidase technique (Dako, Carpinteria, CA, USA). After
deparaffination, rehydration and blockade of endogenous peroxi-
dase activity, heat-induced antigen retrieval was performed in Tris-
EDTA buffer (pH 9.0). Afterantigen retrievalsections werecovered
with serum-free protein block (Dako) for 1 hr, followed by
incubation with anti-human Foxp3 (e-biosciences, San Diego,
USA) for 1 hr and EnVision1 anti-mouse/horseradish peroxidase
(HRP) polymer (Dako) for 30 min at room temperature. Color was
developed using diaminobenzidine (DAB1) chromogen system.
Statistical analysis
Statistical analysis was performed using Graph Pad Prism 5
(GraphPad Software, Inc., San Diego, CA, USA). Correlation was
evaluated using Spearman/Pearson correlation test. P values of
less than 0.05 were considered significant.
Results
Localized levels of Treg cell markers and IL-10 increased
in PKDL
Natural Treg markers and IL-10 mRNA level were evaluated in
skin lesion tissues of PKDL patients and compared with healthy
controls tissues. mRNA analysis showed significantly elevated levels
of nTreg markers in pre-treatment cases compared to control
(Foxp3, P=0.0009; CD25 & CTLA-4, P,0.0001) (Figure 1A).
After treatment, a significant decrement in mRNA levels (Foxp3,
P=0.0025; CD25, P=0.0002 & CTLA-4, P,0.0001) was noticed
in paired samples (Figure 1B). In addition, we evaluated mRNA
levels of IL-10, a molecule produced by adaptive Treg or Tr1 cells,
and frequently associated with experimental or human VL
pathology [5–7]. IL-10 mRNA level was significantly elevated in
PKDL compared to control (P,0.0001). A significant drop in IL-10
mRNA levels was noticed in paired samples (P=0.0004) (Figure 1).
Intralesional expression of CD25, Foxp3 and IL-10
correlated with parasite load
To further evaluate whether there is any direct association
between expression of these molecules and parasite burden, we
evaluated the parasite load in PKDL lesion tissues (n=15). The
median parasite load was 776 parasites/mg tissue DNA (range=3
to 590,000 parasites/mg tissue DNA), with a higher parasite load in
nodular lesions (median 2,244 parasites/mg tissue DNA, n=10) as
compared to that in papular/macular lesions (median 28
parasites/mg tissue DNA, n=5). Ex vivo analysis showed a direct
correlation between parasite load and mRNA levels in lesion
tissues (CD25, r=0.691; Foxp3, r=0.817; IL-10, r=0.821), such
correlation was not noticed for CTLA-4 (Figure 2). No parasite
was detected in any of the post treatment sample.
Aggregation of Foxp3+ cells in PKDL decreased with
treatment
To authenticate mRNA expression at protein level, IHC
staining for Foxp3 expression was evaluated between groups.
Three PKDL samples showed intense nuclear staining for Foxp3
Figure 1. Ex vivo analysis of mRNA expression of Treg markers and IL-10 in PKDL. Relative mRNA levels of CD25, Foxp3, CTLA-4 and IL-10 in
lesion tissues of PKDL patients determined by real time polymerase chain reaction at pretreatment (n=25) or post treatment (n=8), or control tissues
(n=5) (A) and in paired samples (n=8) shown separately (B). **P,0.01, and ***P,0.001.
doi:10.1371/journal.pntd.0001171.g001
Natural T Regulatory Cells in PKDL
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reduction in Foxp3
+ cells and cell infiltrates. Representative
examples are illustrated in Figure 3.
Expression of Treg markers and IL-10 varied with clinical
manifestation of disease
We investigated preponderance of localized nTregs and IL-10
in nodular tissues compared to macular or papular clinical
manifestations. mRNA analysis showed enhanced CD25, Foxp3
and IL-10 mRNA levels in nodular tissues compared to other
forms (CD25 & Foxp3, P,0.001; IL-10, P=0.006) (Figure 4).
Discussion
During infection, a precise controlled immune response is
desired to protect the host from invading parasites, preventing
untoward immune responses and maintaining homeostasis. nTreg
constitute one such arm of the regulatory network acting as a
double edged sword, on one hand limiting inflammation mediated
pathology, at the same time promoting parasite replication [8].
Recently we have reported a rich parasite burden in nodular tissue
of PKDL patients compared to other forms. Further, we also
showed positive correlation between circulating IL-10 and parasite
burden in human VL [5]. Here we provide evidence for
accumulation of nTreg in PKDL lesion tissues and demonstrate
a direct correlation between CD25, Foxp3 and IL-10 mRNA
levels with parasite load.
At the pre-treatment stage the expression of nTreg cells surface
markers (CD25, CTLA-4 and Foxp3) was found elevated in lesion
tissue compared to control, implicating a role of nTreg in PKDL.
Reports on human CL have documented a possible role of intra-
lesional Treg cells for local control of effector T cell functions and
Figure 2. Correlation of mRNA expression of Treg markers and IL-10 with parasite load in PKDL. Relative mRNA levels of Treg markers
and IL-10 with respect to parasite load within lesion tissues of PKDL patients (n=15). Plot was created using logarithmic values for cycles over 18sRNA
and parasite load. Correlation was calculated using Spearman/Pearson correlation test. Diagonal line represents linear regression.
doi:10.1371/journal.pntd.0001171.g002
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PKDL, human VL was not linked with nTreg accumulation in
blood or spleen, nor was antigen-specific IFN-c response rescued
following depletion of CD25
+ cells [6]. Possible discrepancy
between VL and PKDL could be context dependent due to (i)
different niche and clinical manifestation; (ii) infection induced
inflammation (iii) presence of Treg inducing and proliferating
factors.
Of the human CD4
+ T cells, approximately 30% cells express
CD25. 1–3% of these express CD25 at high levels (CD25
++) that
possess suppressor activity [11]. The present study demonstrated
elevated mRNA expression of CD25 in lesion tissue of patients
and the level subsided after treatment, suggesting accumulation of
Treg in lesion tissues supported by immunohistochemical
identification of Foxp3+ cells. In Sudanese PKDL, scanty
CD25+ cells in tissue biopsy are documented [12], contrary to
this we noticed enhanced CD25 expression in all patients, which
could be due to differences in the ethnic composition of the two
populations or strains of the parasites. Thus, the finding suggests
the variation in regulatory cells population according to the
Figure 3. Immunohistochemical analysis of Foxp3 in tissue lesions of PKDL patients. Distribution of Foxp3 in dermal lesion tissue sections
at pre treatment, post treatment stages and normal skin of healthy individuals. Panel A (106), Panel B (406) magnification.
doi:10.1371/journal.pntd.0001171.g003
Figure 4. Ex vivo analysis of mRNA expression in different clinical manifestations of PKDL. Ex vivo analysis of relative Treg markers and IL-
10 mRNA levels in Nodular (N) (n=12) and Macular/Papular (M/P) (n=10) lesions in distinct forms of PKDL. ***P,0.001.
doi:10.1371/journal.pntd.0001171.g004
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suggests a distinct PKDL pathology in comparison with Indian VL
or Sudanese PKDL.
The correlation between advent of host immune responses and
parasite persistence has been demonstrated in various Leishmania
infections [5,13,14]. Analysis of Foxp3 and CD25 mRNA levels
and parasite load showed direct correlation in lesion tissues.
Furthermore, nodular lesions have rich parasite burden compared
to other forms, indicating that chronic infection in the skin might
have generated a population of Treg cells that have influence on
parasite propagation and the level of immunity. Numerous recent
observations have shown influence of nTreg on functional
immunity against several microbes including human malaria
parasite [15].
Similar correlation with parasite load was lacking for CTLA-4,
although mRNA was enhanced at pretreatment stage. CTLA-4
(CD152) is expressed on activated CD4+ and CD8+ T cells and
binds to the costimulatory ligands, B7-1 (CD80) and B7-2 (CD86),
with a 20-fold higher affinity than CD28 [16,17]. CTLA-4
expression is not detected on naive T cells, but transcriptionally
induced after T cell activation [18]. CTLA-4 can out-compete
CD28 for binding with co-stimulatory ligands, especially when
these molecules are limiting, and low level of CD28 expression on
circulating T cells is reported in PKDL [19]. Thus, in the context
of enhanced CTLA-4 at pretreatment stage, data suggests
inhibitory local signals in lesion tissues. In murine VL, blockage
of CTLA-4 results in beneficial effect, in the form of low parasite
burden and increment in the frequency of IFN-c and IL-4
producing cells in spleen and liver [20]. Further studies are needed
to understand the extent to which CTLA-4 contributes its effect
either on regulatory T cells or activated Th1 cells or on both and if
blockage of CTLA-4 has any influence on functional immunity in
human PKDL.
IL-10 is repeatedly implicated as an immunosuppressive factor
in both human and experimental leishmaniasis. The role of IL-10
in KA and PKDL is well documented [4,5] and a consistent
correlation between IL-10 levels and the development of PKDL in
Sudanese KA patients has been established [21]. Like nTreg
markers, IL-10 mRNA level was enhanced in PKDL lesion tissues
at pretreatment stage, the level subsided following treatment,
similar to previous observations [4,6]. Additionally, like Foxp3 and
CD25, IL-10 mRNA level directly correlated with parasite
burden, and was high in nodular lesions compared with other
form, probably due to preponderance of nTreg and other cellular
infiltrates in nodular lesions. Furthermore, in mice IL-10 is found
to be important for the maintenance of Treg activity [22].
Immunopathology of different clinical manifestations of PKDL
is not well understood. There is higher cellular infiltration
including T cells and plasma cells in nodular PKDL compared
to macular or papular forms [23,24]. In addition, we have recently
demonstrated [5], and also observed in the present study, a higher
parasite burden in nodular lesions compared to macular or
papular lesions. Abundance of nTreg with IL-10 in tissue
infiltrates of nodular form, observed in the present study, may
be the driving factors for high parasite burden resulting in disease
aggravation.
Collectively the data suggests a possible role of Treg and IL-10
in parasite establishment in PKDL patients. Because nTreg have
been shown to produce IL-10 and TGF-b associated with immune
suppression in experimental systems, studies are warranted to
explore antigen specific IL-10 source in PKDL lesion tissues.
Furthermore functional studies are required to support the
association of Treg and immunosuppression in PKDL. Such
findings will lead to new targets for immunotherapeutic or vaccine
strategies against PKDL, important from the perspective of
parasite reservoir/transmission and a barrier towards VL
eradication.
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